Friday July 19, 2019
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • Home
  • #46142 (no title)
    • Analytical, Formulation and Quality
    • Cell Culture & Upstream Processing
    • Drug Product Manufacturing & Fill-Finish Processing
    • Early Stage Biologics and Companies
    • Manufacturing Strategy
    • Podcast Sponsors
      • Charter Medical
      • Fujifilm Diosynth Biotechnologies
      • Gyros
      • ILC Dover
      • Pall Life Sciences
    • Recovery & Purification
  • #60015 (no title)
    • Cell Culture & Upstream Processing
    • Recovery & Purification
    • Bioprocessing 4.0 – The Path to Smart Manufacturing
    • Analytical & Quality
    • Speed from Gene to Market
    • 2018 BioProcess International Conference & Exhibition Pre-Event Planner
  • 2014-07-10 PDF test 01
  • 2016 BioProcess International Awards
    • Best Collaboration Finalists – 2016 BioProcess International Awards
    • Best Technology Application – ANALYTICAL Finalists
    • Best Technology Application – DOWNSTREAM Finalists
    • Best Technology Application – UPSTREAM Finalists
    • Corporate Citizenship Award Finalists – 2016 BioProcess International Awards
    • Emerging Company Finalists – 2016 BioProcess International Awards
    • Excellence in Facility Design or Retrofit Finalists – 2016 BioProcess International Awards
    • Excellence in Leadership Award Finalists – 2016 BioProcess International Awards
    • FAQs: BioProcess International 2016 Awards
    • Past Winners of BioProcess International Awards
  • A New Paradigm in Process Development: To Accelerate Biologic Manufacturing of MAbs, Vaccines, and Novel Biotherapies
  • Addressing High Demands for Increased Productivity in Downstream Operations
  • Advances in Single-Use Platforms for Commercial Manufacturing
  • Antibody-Drug Conjugates: Focus on Cancer Treatment
  • April 2019 – Smart(er) Facilities for Biomanufacturing
  • Biopharmaceutical Training Supplement
  • BPI Conf Home
  • Cookie Policy
  • eBooks
  • Events
  • Featured Reports
  • Industry Innovators: 2018-2019
    • Upstream Processing — Industry Innovators: 2018-2019
    • Downstream Processing — Industry Innovators 2018-2019
    • Manufacturing — Industry Innovators 2018-2019
    • Analytical Methods and Instrumentation — Industry Innovators 2018-2019
  • Issue Archive
    • 2019 Archive
    • 2018 Archive
    • 2017 Archive
    • 2016 Archive
    • 2015 Archive
    • 2014 Archive
    • 2013 Archive
    • 2012 Archive
    • 2011 Archive
    • 2010 Archive
    • 2009 Archive
    • 2008 Archive
    • 2007 Archive
    • 2006 Archive
    • 2005 Archive
    • 2004 Archive
    • 2003 Archive
  • January-February 2019 Featured Report
  • Large-Scale Capacity Strategy
  • March 2019 Featured Report: Addressing Challenges in Formulation
  • November 2018 Featured Report: The Biopharmaceutical Supply Chain
  • October 2018 Featured Report: Bioassays
  • Roundtables
  • September 2018 Featured Report: Cell Line Development
  • State of the Industry – 2017 BioProcess International Special Issue
    • The Regulatory Affairs Perspective: Addressing Compliance in a Changing Industry – Chapter 5
    • The Supply-Chain Management Perspective: Managing Risks and Guarding Against Disruption – Chapter 6
    • The Bioexecutive Perspective: Business Strategies for a Rapidly Maturing Industry – Chapter 1
    • The Laboratory Manager’s Perspective: Ensuring Efficiency, Data Integrity, and Compliance
    • The Project Manager’s Perspective: Managing Timelines, Budgets, and Milestones in Multidisciplinary Teams – Chapter 3
    • The R&D Perspective: Mapping New Pathways from Discovery to Development – Chapter 4
    • The Process Development Perspective: Implementing Tools for Optimization – Chapter 7
    • The Manufacturing Perspective: Current Approaches to Bioprocess Intensification – Chapter 8
    • The Technology Transfer Perspective: Modern Approaches and Challenges – Chapter 9
    • The Engineer’s Perspective: Transforming Science into Technology – Chapter 10
    • The Analyst’s Perspective: Ensuring and Controlling Quality of Well-Characterized Biologics – Chapter 11
  • About
    • Who We Are
    • Management Team
    • Editorial Advisors
    • Author Guidelines
      • Article Submission Details
      • House Style and Copy-Editing Practices
      • Submitting Graphics
        (Photos and Figures) to BPI
    • Advertising/Media Kit
    • List Rental/Reprints
    • Contact Us
    • Careers
    • BPA Statement
  • Awards
  • Resources
  • Register
  • Registration Successful
  • Contribute
  • Download PDF
  • Email Newsletters
  • Subscribe
  • Account
  • Privacy Policy
  • Site Map

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

A New Generation of Generic HCP Assays

by BPI Contributor Monday, May 5, 2014  9:01 am

A New Generation of Generic HCP Assays

← Older Post

Editor’s Choice

  • BioProcess Insider

    Cannabis culture: Cronos buys 102,000 L microbial plant from Apotex

  • BioProcess Insider

    Single-use techs are garbage, eventually, and that’s great for biopharma

  • Sponsored Content

    Single-Use Stirred-Tank Bioreactors: A Commercially Viable Strategy for Cell Therapy Manufacturing

  • BioProcess Insider

    Spark on the evolving commercial cell & gene therapy space

  • BioProcess Insider

    AbbVie: Lack of Botox biosimilars a factor in $63bn Allergan buy

  • Sponsored Content

    Process Development of a Closed CAR-T Manufacturing Process

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: J&J has reported 57% year-on-year growth for its #multiplemyeloma monoclonal antibody Darzalex and is now hoping to… https://t.co/nt3kkGe1M6 2 days ago
  • Tweet Avatar RT @Dan5tanton: Kite will build a 67,000 square-foot facility within its parent company Gilead’s site in Oceanside, California to e… https://t.co/ucdPJg3fWA 3 days ago
  • Tweet Avatar Boehringer Ingelheim to buy cancer vaccine firm AMAL - The $365m acquisition is latest boost in the immune cell-di… https://t.co/Su3nVXiuVB 3 days ago
  • Tweet Avatar RT @Dan5tanton: ADC Bio has completed construction of a cleanroom in Wales, part of an $11m bioconjugation facility to serve demand… https://t.co/8ONhj1Js3U 3 days ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    Single-use techs are garbage, eventually, and that’s great for biopharma

  • BioProcess Insider

    Bluebird’s gene therapy latest to feel ‘inevitable’ teething problems

  • BioProcess Insider

    CDMO Celonic jumping into cell & gene therapies with €50m plant

  • BioProcess Insider

    Biocon going digital to fix insulin plant hit with another FDA 483

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Management Team
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers.
BPI
twitter linkedin
Site Map|Privacy policy|Contact
©2019 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BioProcess International Boston 2019
    • BioProduction 2019
  • BioProcess International Academy
  • Events